Inventor
MOSS BERNARD
US45 patents
⚠️ This page may combine multiple inventors who share the name “MOSS BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
21 patentsUS7045313B1May 16, 2006
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
US HEALTH86 citations97
US6998252B1Feb 14, 2006
Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
US HEALTH121 citations97
US7208313B2Apr 24, 2007
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
US HEALTH53 citations92
US7045136B1May 16, 2006
Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
US HEALTH14 citations91
US7015024B1Mar 21, 2006
Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
US HEALTH22 citations91
US6171596B1Jan 9, 2001
Oligomeric HIV-1 envelope glycoproteins
US HEALTH35 citations91
US5135855AAug 4, 1992
Rapid, versatile and simple system for expressing genes in eukaryotic cells
US HEALTH49 citations90
US5126251AJun 30, 1992
Stable mammalian cell line expressing a bacteriophage RNA polymerase
US HEALTH27 citations90
US5157110AOct 20, 1992
Synthetic, anti-complement protein
US HEALTH37 citations89
US6780417B2Aug 24, 2004
Transmission blocking immunogen from malaria
US HEALTH19 citations88
US5336758AAug 9, 1994
Peptides stimulating cytotoxic T cells immune to HIV RT
US HEALTH23 citations86
US9879231B2Jan 30, 2018
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
US HEALTH7 citations81
US5866383AFeb 2, 1999
In vitro ligation of foreign DNA into large eukaryotic viruses
US HEALTH18 citations78
US7303754B2Dec 4, 2007
MVA expressing modified HIV envelope, gag, and pol genes
US HEALTH12 citations76
US6039957AMar 21, 2000
Oligomeric HIV-1 envelope glycoproteins
US HEALTH8 citations72
US5164313ANov 17, 1992
Recombinant vaccinia virus encoding cytochromes P-450
US HEALTH10 citations71
US5187268AFeb 16, 1993
Gene encoding an anti-complement protein from vaccinia
US HEALTH9 citations70
US7914788B2Mar 29, 2011
Monoclonal antibodies against orthopoxviruses
US HEALTH3 citations62
US9708392B2Jul 18, 2017
Monoclonal antibodies against orthopoxviruses
US HEALTH0 citations51
US8999336B2Apr 7, 2015
Monoclonal antibodies against Orthopoxviruses
US HEALTH0 citations51
US7494813B2Feb 24, 2009
VAC-BAC shuttle vector system
US HEALTH1 citations51
US COMMERCE
5 patentsUS5587455ADec 24, 1996
Cytotoxic agent against specific virus infection
US COMMERCE28 citations92
US5206353AApr 27, 1993
CD-4/cytotoxic gene fusions
US COMMERCE26 citations92
US5428143AJun 27, 1995
Cytotoxic agent against specific virus infection
US COMMERCE9 citations73
US5849304ADec 15, 1998
Recombinant vaccinia virus expressing human retrovirus gene
US COMMERCE13 citations70
US5770210AJun 23, 1998
Recombinant vaccinia virus expressing human retrovirus gene
US COMMERCE0 citations49
MOSS BERNARD
4 patentsUS9133480B2Sep 15, 2015
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
MOSS BERNARD23 citations89
US9133478B2Sep 15, 2015
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes
MOSS BERNARD17 citations89
US9453239B2Sep 27, 2016
Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes
MOSS BERNARD7 citations82
US8916172B2Dec 23, 2014
MVA expressing modified HIV envelope, gag, and pol genes
MOSS BERNARD9 citations81